Here, we describe its biological properties in vitro, its capacity of expanding NK and CD8+ T cells but not Tregs in a tumoral setting, and its high anti-tumor potency in vivo, highlighting its potential clinical benefit in B-cell malignancies. This evidence concerns the gene CD8A and neoplasm.